nodes	percent_of_prediction	percent_of_DWPC	metapath
Bedaquiline—Toremifene—breast cancer	0.28	0.614	CrCtD
Bedaquiline—Tamoxifen—breast cancer	0.176	0.386	CrCtD
Bedaquiline—CYP3A4—breast cancer	0.108	1	CbGaD
Bedaquiline—Naftifine—Toremifene—breast cancer	0.0357	0.157	CrCrCtD
Bedaquiline—Tamoxifen—Toremifene—breast cancer	0.0296	0.13	CrCrCtD
Bedaquiline—Toremifene—Tamoxifen—breast cancer	0.0271	0.119	CrCrCtD
Bedaquiline—Naftifine—Tamoxifen—breast cancer	0.0224	0.0987	CrCrCtD
Bedaquiline—Bromodiphenhydramine—Toremifene—breast cancer	0.021	0.0922	CrCrCtD
Bedaquiline—CYP3A4—Exemestane—breast cancer	0.0208	0.133	CbGbCtD
Bedaquiline—CYP3A4—Letrozole—breast cancer	0.0177	0.113	CbGbCtD
Bedaquiline—Clofedanol—Toremifene—breast cancer	0.017	0.0749	CrCrCtD
Bedaquiline—Orphenadrine—Toremifene—breast cancer	0.0165	0.0724	CrCrCtD
Bedaquiline—CYP3A4—Anastrozole—breast cancer	0.0158	0.101	CbGbCtD
Bedaquiline—Diphenhydramine—Toremifene—breast cancer	0.0146	0.0643	CrCrCtD
Bedaquiline—CYP3A4—Toremifene—breast cancer	0.0144	0.0921	CbGbCtD
Bedaquiline—CYP3A4—Fulvestrant—breast cancer	0.0134	0.0856	CbGbCtD
Bedaquiline—Bromodiphenhydramine—Tamoxifen—breast cancer	0.0132	0.0579	CrCrCtD
Bedaquiline—CYP3A4—Thiotepa—breast cancer	0.012	0.0763	CbGbCtD
Bedaquiline—CYP3A4—Ixabepilone—breast cancer	0.0109	0.0698	CbGbCtD
Bedaquiline—Clofedanol—Tamoxifen—breast cancer	0.0107	0.047	CrCrCtD
Bedaquiline—CYP3A4—Lapatinib—breast cancer	0.0105	0.0672	CbGbCtD
Bedaquiline—Orphenadrine—Tamoxifen—breast cancer	0.0103	0.0455	CrCrCtD
Bedaquiline—Diphenhydramine—Tamoxifen—breast cancer	0.00918	0.0404	CrCrCtD
Bedaquiline—CYP3A4—Raloxifene—breast cancer	0.00798	0.0509	CbGbCtD
Bedaquiline—CYP3A4—Vinorelbine—breast cancer	0.00584	0.0372	CbGbCtD
Bedaquiline—CYP3A4—Tamoxifen—breast cancer	0.00527	0.0336	CbGbCtD
Bedaquiline—CYP3A4—Mitoxantrone—breast cancer	0.00514	0.0328	CbGbCtD
Bedaquiline—CYP3A4—Paclitaxel—breast cancer	0.00411	0.0262	CbGbCtD
Bedaquiline—CYP3A4—Irinotecan—breast cancer	0.00405	0.0258	CbGbCtD
Bedaquiline—CYP3A4—Vinblastine—breast cancer	0.0036	0.023	CbGbCtD
Bedaquiline—CYP3A4—Docetaxel—breast cancer	0.00297	0.0189	CbGbCtD
Bedaquiline—CYP3A4—Doxorubicin—breast cancer	0.00221	0.0141	CbGbCtD
Bedaquiline—Tamoxifen—ESRRA—breast cancer	0.000331	0.233	CrCbGaD
Bedaquiline—Tamoxifen—SULT1A1—breast cancer	0.000251	0.177	CrCbGaD
Bedaquiline—Toremifene—ESR1—breast cancer	0.000109	0.0767	CrCbGaD
Bedaquiline—Toremifene—CYP1A1—breast cancer	8.71e-05	0.0613	CrCbGaD
Bedaquiline—Orphenadrine—SCN10A—breast cancer	8.18e-05	0.0576	CrCbGaD
Bedaquiline—Rash—Raloxifene—breast cancer	7.94e-05	0.00159	CcSEcCtD
Bedaquiline—Rash—Idarubicin—breast cancer	7.94e-05	0.00159	CcSEcCtD
Bedaquiline—Dermatitis—Raloxifene—breast cancer	7.93e-05	0.00158	CcSEcCtD
Bedaquiline—Dermatitis—Idarubicin—breast cancer	7.93e-05	0.00158	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Goserelin—breast cancer	7.9e-05	0.00158	CcSEcCtD
Bedaquiline—Decreased appetite—Tamoxifen—breast cancer	7.89e-05	0.00158	CcSEcCtD
Bedaquiline—Headache—Idarubicin—breast cancer	7.89e-05	0.00158	CcSEcCtD
Bedaquiline—Headache—Raloxifene—breast cancer	7.89e-05	0.00158	CcSEcCtD
Bedaquiline—Nausea—Letrozole—breast cancer	7.88e-05	0.00157	CcSEcCtD
Bedaquiline—Nausea—Anastrozole—breast cancer	7.88e-05	0.00157	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Capecitabine—breast cancer	7.85e-05	0.00157	CcSEcCtD
Bedaquiline—Arrhythmia—Gemcitabine—breast cancer	7.85e-05	0.00157	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Tamoxifen—breast cancer	7.84e-05	0.00157	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Paclitaxel—breast cancer	7.75e-05	0.00155	CcSEcCtD
Bedaquiline—Arthralgia—Thiotepa—breast cancer	7.74e-05	0.00155	CcSEcCtD
Bedaquiline—Myalgia—Thiotepa—breast cancer	7.74e-05	0.00155	CcSEcCtD
Bedaquiline—Decreased appetite—Melphalan—breast cancer	7.73e-05	0.00154	CcSEcCtD
Bedaquiline—Arrhythmia—Fluorouracil—breast cancer	7.71e-05	0.00154	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Capecitabine—breast cancer	7.69e-05	0.00154	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Melphalan—breast cancer	7.67e-05	0.00153	CcSEcCtD
Bedaquiline—Nervous system disorder—Vinorelbine—breast cancer	7.62e-05	0.00152	CcSEcCtD
Bedaquiline—Decreased appetite—Goserelin—breast cancer	7.54e-05	0.00151	CcSEcCtD
Bedaquiline—Nausea—Raloxifene—breast cancer	7.48e-05	0.00149	CcSEcCtD
Bedaquiline—Nausea—Idarubicin—breast cancer	7.48e-05	0.00149	CcSEcCtD
Bedaquiline—Anorexia—Vinorelbine—breast cancer	7.4e-05	0.00148	CcSEcCtD
Bedaquiline—Nervous system disorder—Thiotepa—breast cancer	7.27e-05	0.00145	CcSEcCtD
Bedaquiline—Connective tissue disorder—Paclitaxel—breast cancer	7.23e-05	0.00144	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Vinorelbine—breast cancer	7.08e-05	0.00141	CcSEcCtD
Bedaquiline—Anorexia—Thiotepa—breast cancer	7.07e-05	0.00141	CcSEcCtD
Bedaquiline—Tamoxifen—ESR2—breast cancer	7.06e-05	0.0497	CrCbGaD
Bedaquiline—Diarrhoea—Chlorambucil—breast cancer	6.98e-05	0.00139	CcSEcCtD
Bedaquiline—Hepatic function abnormal—Epirubicin—breast cancer	6.95e-05	0.00139	CcSEcCtD
Bedaquiline—Cardiac disorder—Paclitaxel—breast cancer	6.82e-05	0.00136	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Thiotepa—breast cancer	6.76e-05	0.00135	CcSEcCtD
Bedaquiline—Decreased appetite—Vinorelbine—breast cancer	6.75e-05	0.00135	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Vinorelbine—breast cancer	6.71e-05	0.00134	CcSEcCtD
Bedaquiline—Myalgia—Mitoxantrone—breast cancer	6.68e-05	0.00133	CcSEcCtD
Bedaquiline—Arthralgia—Mitoxantrone—breast cancer	6.68e-05	0.00133	CcSEcCtD
Bedaquiline—Chest pain—Mitoxantrone—breast cancer	6.68e-05	0.00133	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Methotrexate—breast cancer	6.63e-05	0.00132	CcSEcCtD
Bedaquiline—Arrhythmia—Paclitaxel—breast cancer	6.57e-05	0.00131	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Docetaxel—breast cancer	6.57e-05	0.00131	CcSEcCtD
Bedaquiline—Chest pain—Gemcitabine—breast cancer	6.51e-05	0.0013	CcSEcCtD
Bedaquiline—Myalgia—Gemcitabine—breast cancer	6.51e-05	0.0013	CcSEcCtD
Bedaquiline—Arthralgia—Gemcitabine—breast cancer	6.51e-05	0.0013	CcSEcCtD
Bedaquiline—Vomiting—Chlorambucil—breast cancer	6.48e-05	0.0013	CcSEcCtD
Bedaquiline—Decreased appetite—Thiotepa—breast cancer	6.45e-05	0.00129	CcSEcCtD
Bedaquiline—Tamoxifen—CYP1B1—breast cancer	6.44e-05	0.0453	CrCbGaD
Bedaquiline—Hepatic function abnormal—Doxorubicin—breast cancer	6.43e-05	0.00129	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Thiotepa—breast cancer	6.4e-05	0.00128	CcSEcCtD
Bedaquiline—Chest pain—Fluorouracil—breast cancer	6.4e-05	0.00128	CcSEcCtD
Bedaquiline—Myalgia—Fluorouracil—breast cancer	6.4e-05	0.00128	CcSEcCtD
Bedaquiline—Diarrhoea—Vinblastine—breast cancer	6.39e-05	0.00128	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Capecitabine—breast cancer	6.36e-05	0.00127	CcSEcCtD
Bedaquiline—Nervous system disorder—Irinotecan—breast cancer	6.28e-05	0.00125	CcSEcCtD
Bedaquiline—Hepatitis—Docetaxel—breast cancer	6.23e-05	0.00124	CcSEcCtD
Bedaquiline—Diarrhoea—Tamoxifen—breast cancer	6.21e-05	0.00124	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Epirubicin—breast cancer	6.2e-05	0.00124	CcSEcCtD
Bedaquiline—Dizziness—Vinblastine—breast cancer	6.18e-05	0.00123	CcSEcCtD
Bedaquiline—Connective tissue disorder—Docetaxel—breast cancer	6.12e-05	0.00122	CcSEcCtD
Bedaquiline—Nervous system disorder—Gemcitabine—breast cancer	6.12e-05	0.00122	CcSEcCtD
Bedaquiline—Anorexia—Mitoxantrone—breast cancer	6.11e-05	0.00122	CcSEcCtD
Bedaquiline—Anorexia—Irinotecan—breast cancer	6.11e-05	0.00122	CcSEcCtD
Bedaquiline—Diarrhoea—Melphalan—breast cancer	6.08e-05	0.00122	CcSEcCtD
Bedaquiline—Nausea—Chlorambucil—breast cancer	6.06e-05	0.00121	CcSEcCtD
Bedaquiline—Hepatitis—Capecitabine—breast cancer	6.03e-05	0.00121	CcSEcCtD
Bedaquiline—Nervous system disorder—Fluorouracil—breast cancer	6.02e-05	0.0012	CcSEcCtD
Bedaquiline—Dizziness—Tamoxifen—breast cancer	6e-05	0.0012	CcSEcCtD
Bedaquiline—Anorexia—Gemcitabine—breast cancer	5.95e-05	0.00119	CcSEcCtD
Bedaquiline—Vomiting—Vinblastine—breast cancer	5.94e-05	0.00119	CcSEcCtD
Bedaquiline—Diarrhoea—Goserelin—breast cancer	5.93e-05	0.00119	CcSEcCtD
Bedaquiline—Connective tissue disorder—Capecitabine—breast cancer	5.93e-05	0.00118	CcSEcCtD
Bedaquiline—Headache—Vinblastine—breast cancer	5.85e-05	0.00117	CcSEcCtD
Bedaquiline—Anorexia—Fluorouracil—breast cancer	5.85e-05	0.00117	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Mitoxantrone—breast cancer	5.84e-05	0.00117	CcSEcCtD
Bedaquiline—Cardiac disorder—Docetaxel—breast cancer	5.78e-05	0.00116	CcSEcCtD
Bedaquiline—Vomiting—Tamoxifen—breast cancer	5.77e-05	0.00115	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Doxorubicin—breast cancer	5.74e-05	0.00115	CcSEcCtD
Bedaquiline—Dizziness—Goserelin—breast cancer	5.73e-05	0.00115	CcSEcCtD
Bedaquiline—Rash—Tamoxifen—breast cancer	5.72e-05	0.00114	CcSEcCtD
Bedaquiline—Dermatitis—Tamoxifen—breast cancer	5.72e-05	0.00114	CcSEcCtD
Bedaquiline—Headache—Tamoxifen—breast cancer	5.69e-05	0.00114	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Gemcitabine—breast cancer	5.68e-05	0.00114	CcSEcCtD
Bedaquiline—Vomiting—Melphalan—breast cancer	5.65e-05	0.00113	CcSEcCtD
Bedaquiline—Rash—Melphalan—breast cancer	5.61e-05	0.00112	CcSEcCtD
Bedaquiline—Cardiac disorder—Capecitabine—breast cancer	5.6e-05	0.00112	CcSEcCtD
Bedaquiline—Dermatitis—Melphalan—breast cancer	5.6e-05	0.00112	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Fluorouracil—breast cancer	5.59e-05	0.00112	CcSEcCtD
Bedaquiline—Decreased appetite—Irinotecan—breast cancer	5.57e-05	0.00111	CcSEcCtD
Bedaquiline—Decreased appetite—Mitoxantrone—breast cancer	5.57e-05	0.00111	CcSEcCtD
Bedaquiline—Arrhythmia—Docetaxel—breast cancer	5.57e-05	0.00111	CcSEcCtD
Bedaquiline—Toremifene—CYP3A4—breast cancer	5.56e-05	0.0391	CrCbGaD
Bedaquiline—Nausea—Vinblastine—breast cancer	5.55e-05	0.00111	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Irinotecan—breast cancer	5.53e-05	0.0011	CcSEcCtD
Bedaquiline—Vomiting—Goserelin—breast cancer	5.51e-05	0.0011	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Epirubicin—breast cancer	5.47e-05	0.00109	CcSEcCtD
Bedaquiline—Rash—Goserelin—breast cancer	5.47e-05	0.00109	CcSEcCtD
Bedaquiline—Dermatitis—Goserelin—breast cancer	5.46e-05	0.00109	CcSEcCtD
Bedaquiline—Chest pain—Paclitaxel—breast cancer	5.45e-05	0.00109	CcSEcCtD
Bedaquiline—Myalgia—Paclitaxel—breast cancer	5.45e-05	0.00109	CcSEcCtD
Bedaquiline—Arthralgia—Paclitaxel—breast cancer	5.45e-05	0.00109	CcSEcCtD
Bedaquiline—Headache—Goserelin—breast cancer	5.43e-05	0.00109	CcSEcCtD
Bedaquiline—Decreased appetite—Gemcitabine—breast cancer	5.42e-05	0.00108	CcSEcCtD
Bedaquiline—Nausea—Tamoxifen—breast cancer	5.39e-05	0.00108	CcSEcCtD
Bedaquiline—Arrhythmia—Capecitabine—breast cancer	5.39e-05	0.00108	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Gemcitabine—breast cancer	5.39e-05	0.00108	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Epirubicin—breast cancer	5.36e-05	0.00107	CcSEcCtD
Bedaquiline—Decreased appetite—Fluorouracil—breast cancer	5.33e-05	0.00107	CcSEcCtD
Bedaquiline—Diarrhoea—Vinorelbine—breast cancer	5.31e-05	0.00106	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Fluorouracil—breast cancer	5.3e-05	0.00106	CcSEcCtD
Bedaquiline—Nausea—Melphalan—breast cancer	5.28e-05	0.00105	CcSEcCtD
Bedaquiline—Nausea—Goserelin—breast cancer	5.15e-05	0.00103	CcSEcCtD
Bedaquiline—Dizziness—Vinorelbine—breast cancer	5.14e-05	0.00103	CcSEcCtD
Bedaquiline—Nervous system disorder—Paclitaxel—breast cancer	5.12e-05	0.00102	CcSEcCtD
Bedaquiline—Diarrhoea—Thiotepa—breast cancer	5.07e-05	0.00101	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Doxorubicin—breast cancer	5.06e-05	0.00101	CcSEcCtD
Bedaquiline—Anorexia—Paclitaxel—breast cancer	4.98e-05	0.000995	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Doxorubicin—breast cancer	4.96e-05	0.000991	CcSEcCtD
Bedaquiline—Vomiting—Vinorelbine—breast cancer	4.94e-05	0.000986	CcSEcCtD
Bedaquiline—Dizziness—Thiotepa—breast cancer	4.9e-05	0.00098	CcSEcCtD
Bedaquiline—Rash—Vinorelbine—breast cancer	4.9e-05	0.000978	CcSEcCtD
Bedaquiline—Dermatitis—Vinorelbine—breast cancer	4.89e-05	0.000977	CcSEcCtD
Bedaquiline—Headache—Vinorelbine—breast cancer	4.87e-05	0.000972	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Paclitaxel—breast cancer	4.76e-05	0.000951	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Methotrexate—breast cancer	4.73e-05	0.000945	CcSEcCtD
Bedaquiline—Tamoxifen—CYP19A1—breast cancer	4.73e-05	0.0333	CrCbGaD
Bedaquiline—Vomiting—Thiotepa—breast cancer	4.72e-05	0.000942	CcSEcCtD
Bedaquiline—Rash—Thiotepa—breast cancer	4.68e-05	0.000934	CcSEcCtD
Bedaquiline—Dermatitis—Thiotepa—breast cancer	4.67e-05	0.000933	CcSEcCtD
Bedaquiline—Headache—Thiotepa—breast cancer	4.65e-05	0.000928	CcSEcCtD
Bedaquiline—Toremifene—ABCB1—breast cancer	4.63e-05	0.0326	CrCbGaD
Bedaquiline—Arthralgia—Docetaxel—breast cancer	4.62e-05	0.000923	CcSEcCtD
Bedaquiline—Chest pain—Docetaxel—breast cancer	4.62e-05	0.000923	CcSEcCtD
Bedaquiline—Myalgia—Docetaxel—breast cancer	4.62e-05	0.000923	CcSEcCtD
Bedaquiline—Nausea—Vinorelbine—breast cancer	4.61e-05	0.000922	CcSEcCtD
Bedaquiline—Decreased appetite—Paclitaxel—breast cancer	4.54e-05	0.000907	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Paclitaxel—breast cancer	4.51e-05	0.000901	CcSEcCtD
Bedaquiline—Hepatitis—Methotrexate—breast cancer	4.49e-05	0.000897	CcSEcCtD
Bedaquiline—Arthralgia—Capecitabine—breast cancer	4.47e-05	0.000893	CcSEcCtD
Bedaquiline—Chest pain—Capecitabine—breast cancer	4.47e-05	0.000893	CcSEcCtD
Bedaquiline—Myalgia—Capecitabine—breast cancer	4.47e-05	0.000893	CcSEcCtD
Bedaquiline—Tamoxifen—ABCG2—breast cancer	4.44e-05	0.0313	CrCbGaD
Bedaquiline—Hepatobiliary disease—Epirubicin—breast cancer	4.43e-05	0.000885	CcSEcCtD
Bedaquiline—Nausea—Thiotepa—breast cancer	4.41e-05	0.00088	CcSEcCtD
Bedaquiline—Diarrhoea—Mitoxantrone—breast cancer	4.38e-05	0.000875	CcSEcCtD
Bedaquiline—Diarrhoea—Irinotecan—breast cancer	4.38e-05	0.000875	CcSEcCtD
Bedaquiline—Tamoxifen—ESR1—breast cancer	4.35e-05	0.0306	CrCbGaD
Bedaquiline—Nervous system disorder—Docetaxel—breast cancer	4.34e-05	0.000867	CcSEcCtD
Bedaquiline—Diarrhoea—Gemcitabine—breast cancer	4.27e-05	0.000853	CcSEcCtD
Bedaquiline—Dizziness—Irinotecan—breast cancer	4.24e-05	0.000846	CcSEcCtD
Bedaquiline—Anorexia—Docetaxel—breast cancer	4.22e-05	0.000843	CcSEcCtD
Bedaquiline—Nervous system disorder—Capecitabine—breast cancer	4.2e-05	0.00084	CcSEcCtD
Bedaquiline—Hepatitis—Epirubicin—breast cancer	4.2e-05	0.00084	CcSEcCtD
Bedaquiline—Diarrhoea—Fluorouracil—breast cancer	4.2e-05	0.000838	CcSEcCtD
Bedaquiline—Cardiac disorder—Methotrexate—breast cancer	4.17e-05	0.000833	CcSEcCtD
Bedaquiline—Connective tissue disorder—Epirubicin—breast cancer	4.13e-05	0.000825	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Doxorubicin—breast cancer	4.1e-05	0.000819	CcSEcCtD
Bedaquiline—Anorexia—Capecitabine—breast cancer	4.09e-05	0.000816	CcSEcCtD
Bedaquiline—Vomiting—Irinotecan—breast cancer	4.07e-05	0.000814	CcSEcCtD
Bedaquiline—Vomiting—Mitoxantrone—breast cancer	4.07e-05	0.000814	CcSEcCtD
Bedaquiline—Dizziness—Fluorouracil—breast cancer	4.06e-05	0.00081	CcSEcCtD
Bedaquiline—Rash—Mitoxantrone—breast cancer	4.04e-05	0.000807	CcSEcCtD
Bedaquiline—Rash—Irinotecan—breast cancer	4.04e-05	0.000807	CcSEcCtD
Bedaquiline—Dermatitis—Mitoxantrone—breast cancer	4.03e-05	0.000806	CcSEcCtD
Bedaquiline—Dermatitis—Irinotecan—breast cancer	4.03e-05	0.000806	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Docetaxel—breast cancer	4.03e-05	0.000806	CcSEcCtD
Bedaquiline—Headache—Mitoxantrone—breast cancer	4.01e-05	0.000802	CcSEcCtD
Bedaquiline—Headache—Irinotecan—breast cancer	4.01e-05	0.000802	CcSEcCtD
Bedaquiline—Vomiting—Gemcitabine—breast cancer	3.97e-05	0.000792	CcSEcCtD
Bedaquiline—Rash—Gemcitabine—breast cancer	3.93e-05	0.000786	CcSEcCtD
Bedaquiline—Dermatitis—Gemcitabine—breast cancer	3.93e-05	0.000785	CcSEcCtD
Bedaquiline—Headache—Gemcitabine—breast cancer	3.91e-05	0.000781	CcSEcCtD
Bedaquiline—Diphenhydramine—PTGS1—breast cancer	3.91e-05	0.0275	CrCbGaD
Bedaquiline—Musculoskeletal discomfort—Capecitabine—breast cancer	3.91e-05	0.00078	CcSEcCtD
Bedaquiline—Cardiac disorder—Epirubicin—breast cancer	3.9e-05	0.000779	CcSEcCtD
Bedaquiline—Vomiting—Fluorouracil—breast cancer	3.9e-05	0.000779	CcSEcCtD
Bedaquiline—Hepatitis—Doxorubicin—breast cancer	3.89e-05	0.000777	CcSEcCtD
Bedaquiline—Rash—Fluorouracil—breast cancer	3.87e-05	0.000773	CcSEcCtD
Bedaquiline—Dermatitis—Fluorouracil—breast cancer	3.86e-05	0.000772	CcSEcCtD
Bedaquiline—Decreased appetite—Docetaxel—breast cancer	3.85e-05	0.000769	CcSEcCtD
Bedaquiline—Headache—Fluorouracil—breast cancer	3.84e-05	0.000768	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Docetaxel—breast cancer	3.82e-05	0.000764	CcSEcCtD
Bedaquiline—Connective tissue disorder—Doxorubicin—breast cancer	3.82e-05	0.000764	CcSEcCtD
Bedaquiline—Nausea—Mitoxantrone—breast cancer	3.8e-05	0.00076	CcSEcCtD
Bedaquiline—Nausea—Irinotecan—breast cancer	3.8e-05	0.00076	CcSEcCtD
Bedaquiline—Arrhythmia—Epirubicin—breast cancer	3.76e-05	0.00075	CcSEcCtD
Bedaquiline—Decreased appetite—Capecitabine—breast cancer	3.73e-05	0.000744	CcSEcCtD
Bedaquiline—Nausea—Gemcitabine—breast cancer	3.71e-05	0.00074	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Capecitabine—breast cancer	3.7e-05	0.000739	CcSEcCtD
Bedaquiline—Nausea—Fluorouracil—breast cancer	3.64e-05	0.000728	CcSEcCtD
Bedaquiline—Cardiac disorder—Doxorubicin—breast cancer	3.61e-05	0.000721	CcSEcCtD
Bedaquiline—Diarrhoea—Paclitaxel—breast cancer	3.57e-05	0.000714	CcSEcCtD
Bedaquiline—Tamoxifen—CYP1A1—breast cancer	3.48e-05	0.0245	CrCbGaD
Bedaquiline—Arrhythmia—Doxorubicin—breast cancer	3.47e-05	0.000694	CcSEcCtD
Bedaquiline—Dizziness—Paclitaxel—breast cancer	3.45e-05	0.00069	CcSEcCtD
Bedaquiline—Arthralgia—Methotrexate—breast cancer	3.33e-05	0.000665	CcSEcCtD
Bedaquiline—Chest pain—Methotrexate—breast cancer	3.33e-05	0.000665	CcSEcCtD
Bedaquiline—Myalgia—Methotrexate—breast cancer	3.33e-05	0.000665	CcSEcCtD
Bedaquiline—Vomiting—Paclitaxel—breast cancer	3.32e-05	0.000663	CcSEcCtD
Bedaquiline—Rash—Paclitaxel—breast cancer	3.29e-05	0.000658	CcSEcCtD
Bedaquiline—Dermatitis—Paclitaxel—breast cancer	3.29e-05	0.000657	CcSEcCtD
Bedaquiline—Headache—Paclitaxel—breast cancer	3.27e-05	0.000654	CcSEcCtD
Bedaquiline—Nervous system disorder—Methotrexate—breast cancer	3.13e-05	0.000625	CcSEcCtD
Bedaquiline—Myalgia—Epirubicin—breast cancer	3.12e-05	0.000622	CcSEcCtD
Bedaquiline—Chest pain—Epirubicin—breast cancer	3.12e-05	0.000622	CcSEcCtD
Bedaquiline—Arthralgia—Epirubicin—breast cancer	3.12e-05	0.000622	CcSEcCtD
Bedaquiline—Nausea—Paclitaxel—breast cancer	3.1e-05	0.00062	CcSEcCtD
Bedaquiline—Anorexia—Methotrexate—breast cancer	3.04e-05	0.000608	CcSEcCtD
Bedaquiline—Diarrhoea—Docetaxel—breast cancer	3.03e-05	0.000605	CcSEcCtD
Bedaquiline—Diarrhoea—Capecitabine—breast cancer	2.93e-05	0.000586	CcSEcCtD
Bedaquiline—Nervous system disorder—Epirubicin—breast cancer	2.93e-05	0.000585	CcSEcCtD
Bedaquiline—Dizziness—Docetaxel—breast cancer	2.93e-05	0.000585	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Methotrexate—breast cancer	2.91e-05	0.000581	CcSEcCtD
Bedaquiline—Chest pain—Doxorubicin—breast cancer	2.88e-05	0.000576	CcSEcCtD
Bedaquiline—Myalgia—Doxorubicin—breast cancer	2.88e-05	0.000576	CcSEcCtD
Bedaquiline—Arthralgia—Doxorubicin—breast cancer	2.88e-05	0.000576	CcSEcCtD
Bedaquiline—Anorexia—Epirubicin—breast cancer	2.85e-05	0.000569	CcSEcCtD
Bedaquiline—Dizziness—Capecitabine—breast cancer	2.83e-05	0.000566	CcSEcCtD
Bedaquiline—Vomiting—Docetaxel—breast cancer	2.82e-05	0.000562	CcSEcCtD
Bedaquiline—Rash—Docetaxel—breast cancer	2.79e-05	0.000558	CcSEcCtD
Bedaquiline—Dermatitis—Docetaxel—breast cancer	2.79e-05	0.000557	CcSEcCtD
Bedaquiline—Decreased appetite—Methotrexate—breast cancer	2.77e-05	0.000554	CcSEcCtD
Bedaquiline—Headache—Docetaxel—breast cancer	2.77e-05	0.000554	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Methotrexate—breast cancer	2.76e-05	0.00055	CcSEcCtD
Bedaquiline—Vomiting—Capecitabine—breast cancer	2.73e-05	0.000544	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Epirubicin—breast cancer	2.72e-05	0.000544	CcSEcCtD
Bedaquiline—Nervous system disorder—Doxorubicin—breast cancer	2.71e-05	0.000541	CcSEcCtD
Bedaquiline—Rash—Capecitabine—breast cancer	2.7e-05	0.00054	CcSEcCtD
Bedaquiline—Dermatitis—Capecitabine—breast cancer	2.7e-05	0.000539	CcSEcCtD
Bedaquiline—Headache—Capecitabine—breast cancer	2.69e-05	0.000536	CcSEcCtD
Bedaquiline—Diphenhydramine—CYP2D6—breast cancer	2.66e-05	0.0187	CrCbGaD
Bedaquiline—Anorexia—Doxorubicin—breast cancer	2.63e-05	0.000526	CcSEcCtD
Bedaquiline—Nausea—Docetaxel—breast cancer	2.63e-05	0.000525	CcSEcCtD
Bedaquiline—Decreased appetite—Epirubicin—breast cancer	2.6e-05	0.000519	CcSEcCtD
Bedaquiline—Tamoxifen—CYP2D6—breast cancer	2.59e-05	0.0182	CrCbGaD
Bedaquiline—Gastrointestinal disorder—Epirubicin—breast cancer	2.58e-05	0.000515	CcSEcCtD
Bedaquiline—Nausea—Capecitabine—breast cancer	2.55e-05	0.000509	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.52e-05	0.000503	CcSEcCtD
Bedaquiline—Decreased appetite—Doxorubicin—breast cancer	2.4e-05	0.00048	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Doxorubicin—breast cancer	2.39e-05	0.000477	CcSEcCtD
Bedaquiline—Tamoxifen—CYP3A4—breast cancer	2.22e-05	0.0156	CrCbGaD
Bedaquiline—Diarrhoea—Methotrexate—breast cancer	2.18e-05	0.000436	CcSEcCtD
Bedaquiline—Orphenadrine—CYP3A4—breast cancer	2.16e-05	0.0152	CrCbGaD
Bedaquiline—Dizziness—Methotrexate—breast cancer	2.11e-05	0.000422	CcSEcCtD
Bedaquiline—Diarrhoea—Epirubicin—breast cancer	2.04e-05	0.000408	CcSEcCtD
Bedaquiline—Vomiting—Methotrexate—breast cancer	2.03e-05	0.000405	CcSEcCtD
Bedaquiline—Rash—Methotrexate—breast cancer	2.01e-05	0.000402	CcSEcCtD
Bedaquiline—Dermatitis—Methotrexate—breast cancer	2.01e-05	0.000402	CcSEcCtD
Bedaquiline—Headache—Methotrexate—breast cancer	2e-05	0.000399	CcSEcCtD
Bedaquiline—Dizziness—Epirubicin—breast cancer	1.97e-05	0.000395	CcSEcCtD
Bedaquiline—Vomiting—Epirubicin—breast cancer	1.9e-05	0.000379	CcSEcCtD
Bedaquiline—Nausea—Methotrexate—breast cancer	1.9e-05	0.000379	CcSEcCtD
Bedaquiline—Diarrhoea—Doxorubicin—breast cancer	1.89e-05	0.000378	CcSEcCtD
Bedaquiline—Rash—Epirubicin—breast cancer	1.88e-05	0.000376	CcSEcCtD
Bedaquiline—Dermatitis—Epirubicin—breast cancer	1.88e-05	0.000376	CcSEcCtD
Bedaquiline—Headache—Epirubicin—breast cancer	1.87e-05	0.000374	CcSEcCtD
Bedaquiline—Tamoxifen—ABCB1—breast cancer	1.85e-05	0.013	CrCbGaD
Bedaquiline—Dizziness—Doxorubicin—breast cancer	1.83e-05	0.000365	CcSEcCtD
Bedaquiline—Nausea—Epirubicin—breast cancer	1.77e-05	0.000354	CcSEcCtD
Bedaquiline—Vomiting—Doxorubicin—breast cancer	1.76e-05	0.000351	CcSEcCtD
Bedaquiline—Rash—Doxorubicin—breast cancer	1.74e-05	0.000348	CcSEcCtD
Bedaquiline—Dermatitis—Doxorubicin—breast cancer	1.74e-05	0.000348	CcSEcCtD
Bedaquiline—Headache—Doxorubicin—breast cancer	1.73e-05	0.000346	CcSEcCtD
Bedaquiline—Nausea—Doxorubicin—breast cancer	1.64e-05	0.000328	CcSEcCtD
